Privia Health Group, INC Form 4 insider transactions

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., sold 21,275 shares of common stock on July 9, 2026 for $27.67 per share.

Privia Health Group, Inc. EVP & Chief Financial Officer David Mountcastle reported a sale of 600 shares of common stock, executed under a pre-arranged 10b5-1 trading plan.

Privia Health Group, Inc. Director Matthew Shawn Morris executed trades under a pre-arranged 10b5-1 plan, selling a significant number of shares and exercising stock options.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., reported the sale of 24,734 shares of common stock under a pre-arranged Rule 10b5-1 trading plan.

Privia Health Group, Inc. Director Matthew Shawn Morris executed trades under a Rule 10b5-1 plan, involving the acquisition and disposition of common stock and stock options.

David Mountcastle, EVP & Chief Financial Officer of Privia Health Group, Inc., reported transactions involving the sale of common stock and the exercise of stock options under a pre-arranged Rule 10b5-1 trading plan.

Director Francis S. Soistman Jr. was granted 8,463 restricted stock units in Privia Health Group, Inc.

Privia Health Group director Lance Berberian was granted 8,463 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Director Nancy Cocozza was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Director Pamela Kimmet was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group director Thomas A. McCarthy was granted 8,463 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Director Matthew Morris was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Director Jaewon Ryu was granted 8,463 restricted stock units in Privia Health Group, Inc. as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group, Inc. director David P. King was granted 8,463 restricted stock units as part of the company's 2021 Omnibus Incentive Plan.

Privia Health Group CEO Parth Mehrotra executed a planned sale of 121,086 shares of common stock for tax and trading plan purposes.

Privia Health Group EVP and CFO David Mountcastle sold 3,385 shares to cover tax obligations related to RSU vesting.

Privia Health Group EVP and CFO David Mountcastle exercised stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Director Matthew Morris exercised stock options and sold 18,113 shares of Privia Health Group, Inc. under a 10b5-1 plan.

EVP and CFO David Mountcastle sold 5,566 shares of Privia Health Group to satisfy tax obligations related to RSU vesting.

Privia Health Group's EVP & CFO, David Mountcastle, reported a planned sale of 6,391 common shares at $22.11 each to cover tax withholding from performance stock unit vesting.

Privia Health Group CEO Parth Mehrotra sold 26,509 shares of common stock to cover tax withholding obligations related to vested performance stock units.

Privia Health Group's EVP & CFO, David Mountcastle, sold shares to cover tax withholding obligations related to performance stock unit vesting.

Privia Health Group, Inc. CEO Parth Mehrotra increased his beneficial ownership significantly following the vesting of restricted and performance stock units, alongside a planned sale.

Privia Health Group's EVP & General Counsel, Edward C. Fargis, was granted 28,268 restricted stock units under the company's 2021 Omnibus Incentive Plan.

Privia Health Group's EVP & CFO, David Mountcastle, increased his direct beneficial ownership of common stock through restricted stock unit grants and performance unit vesting.

Privia Health Group Director Matthew Shawn Morris exercised stock options and subsequently sold common stock totaling 24,338 shares in pre-planned transactions.

Privia Health Group, Inc.'s EVP & Chief Financial Officer, David Mountcastle, executed a planned sale of common stock following option exercises.

Privia Health Group Director Matthew Shawn Morris exercised stock options and sold 13,647 shares of common stock for approximately $25.01 per share under a pre-arranged trading plan.

Privia Health Group's EVP & CFO, David Mountcastle, sold 23,887 shares of common stock for approximately $25.03 per share after exercising options, as part of a pre-arranged 10b5-1 trading plan.

Privia Health Group, Inc. Director Lance Berberian was granted 7,668 restricted stock units under the company's 2021 Omnibus Incentive Plan, vesting before the 2026 Annual Meeting.